Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8724473 | Revista Argentina de Endocrinología y Metabolismo | 2016 | 10 Pages |
Abstract
Tyrosine kinase inhibitors are used for the treatment of different types of tumours, interfering in various cell proliferation pathways, and tumour angiogenesis. These oral agents have side effects, thyroid dysfunction outstanding among them. There are different mechanisms through which these agents lead to hypothyroidism, as well as thyrotoxicosis. There is still no consensus on the treatment and follow-up of the above mentioned effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Laila Y. Bielski, Ana M. Orlandi, Hugo R. Boquete,